Completed NA INTERVENTIONAL 2-arm NCT00318188

Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis (SCLEREDUC)

Effects of a Personalized Standardized Rehabilitation Program on the Quality of Life of Patients With Systemic Sclerosis Patients : a Randomized Controlled Trial

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Systemic Scleroderma

Interventions standardized reeducation and readaptation program

Updated 8 times since 2017 Last updated: Mar 9, 2026 Started: Sep 30, 2005 Primary completion: Dec 31, 2011 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00318188, this NA trial focuses on Systemic Scleroderma and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 8 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Mar 2026 — Present [monthly]

Completed NA
Feb 2026 — Mar 2026 [monthly]

Completed NA
Sep 2024 — Feb 2026 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
May 2018 — Jun 2018 [monthly]

Completed NA
Jan 2017 — May 2018 [monthly]

Completed NA

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France